Martin F. Mozes

1.8k total citations
61 papers, 1.2k citations indexed

About

Martin F. Mozes is a scholar working on Transplantation, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Martin F. Mozes has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Transplantation, 28 papers in Surgery and 18 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Martin F. Mozes's work include Renal Transplantation Outcomes and Treatments (31 papers), Organ Donation and Transplantation (15 papers) and Organ Transplantation Techniques and Outcomes (15 papers). Martin F. Mozes is often cited by papers focused on Renal Transplantation Outcomes and Treatments (31 papers), Organ Donation and Transplantation (15 papers) and Organ Transplantation Techniques and Outcomes (15 papers). Martin F. Mozes collaborates with scholars based in United States and Mexico. Martin F. Mozes's co-authors include Raymond Pollak, Olga Jonasson, Vlastimil Capek, Michael S. Maddux, Velta A. Lazda, Warren Kupin, K.K. Venkat, Walter S. Tan, Dimitrios G. Spigos and M Morán and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of Surgery.

In The Last Decade

Martin F. Mozes

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin F. Mozes United States 18 643 349 281 244 196 61 1.2k
D. E. R. Sutherland United States 21 1.1k 1.7× 612 1.8× 167 0.6× 271 1.1× 241 1.2× 93 1.7k
William Pfaff United States 21 1.1k 1.7× 638 1.8× 307 1.1× 119 0.5× 255 1.3× 74 1.9k
Martin L. Milgrom United States 24 1.1k 1.7× 797 2.3× 234 0.8× 446 1.8× 380 1.9× 75 1.8k
P. R. Rajagopalan United States 17 693 1.1× 844 2.4× 194 0.7× 134 0.5× 247 1.3× 59 1.6k
Angelo DeMattos United States 16 398 0.6× 654 1.9× 145 0.5× 200 0.8× 172 0.9× 27 1.3k
E. Bertoni Italy 21 491 0.8× 501 1.4× 218 0.8× 83 0.3× 187 1.0× 94 1.4k
Belzer Fo United States 23 1.1k 1.7× 474 1.4× 286 1.0× 427 1.8× 461 2.4× 119 1.6k
T. Wujciak Germany 14 599 0.9× 796 2.3× 234 0.8× 103 0.4× 243 1.2× 24 1.3k
K. Venkateswara Rao United States 20 364 0.6× 632 1.8× 128 0.5× 252 1.0× 142 0.7× 42 1.1k
T Tojimbara Japan 16 631 1.0× 356 1.0× 130 0.5× 264 1.1× 294 1.5× 81 986

Countries citing papers authored by Martin F. Mozes

Since Specialization
Citations

This map shows the geographic impact of Martin F. Mozes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin F. Mozes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin F. Mozes more than expected).

Fields of papers citing papers by Martin F. Mozes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin F. Mozes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin F. Mozes. The network helps show where Martin F. Mozes may publish in the future.

Co-authorship network of co-authors of Martin F. Mozes

This figure shows the co-authorship network connecting the top 25 collaborators of Martin F. Mozes. A scholar is included among the top collaborators of Martin F. Mozes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin F. Mozes. Martin F. Mozes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lazda, Velta A. & Martin F. Mozes. (2005). An Evaluation of HLA Cross-Reactive Group Matching on Graft Survival in Deceased Donor Kidney Recipients. Transplantation Proceedings. 37(2). 661–663. 4 indexed citations
2.
Kupin, Warren, et al.. (1999). Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients. Transplantation Proceedings. 31(1-2). 1131–1132. 14 indexed citations
3.
4.
Nakhleh, Raouf E., et al.. (1997). Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome. Clinical Transplantation. 11(3). 157–162. 25 indexed citations
5.
Kupin, Warren, et al.. (1997). Separate risk factors for the development of transplant glomerulopathy vs chronic tubulointerstitial rejection. Transplantation Proceedings. 29(1-2). 245–246. 10 indexed citations
6.
Emara, Ashraf M. & Martin F. Mozes. (1995). Cytotoxic T-cell role in renal allograft rejection and regulation. Human Immunology. 42(2). 161–173. 3 indexed citations
7.
Schmidt, Rebecca J., Warren Kupin, Francis Dumler, K.K. Venkat, & Martin F. Mozes. (1993). INFLUENCE OF THE PRETRANSPLANT HEMATOCRIT LEVEL ON EARLY GRAFT FUNCTION IN PRIMARY CADAVERIC RENAL TRANSPLANTATION. Transplantation. 55(5). 1034–1039. 22 indexed citations
8.
Pollak, Raymond, Richard J. Knight, Martin F. Mozes, et al.. (1992). A Trial of the Prostaglandin E1 Analogue, Enisoprost, to Reverse Chronic Cyclosporine-Associated Renal Dysfunction. American Journal of Kidney Diseases. 20(4). 336–341. 12 indexed citations
9.
Schrader, Bruce J., et al.. (1991). Digoxin‐Like Immunoreactive Substance in Renal Transplant Patients. The Journal of Clinical Pharmacology. 31(12). 1126–1131. 4 indexed citations
10.
Venkat, K.K., et al.. (1991). Reversal of cyclosporine-associated hemolytic-uremic syndrome by plasma exchange with fresh-frozen plasma replacement in renal transplant recipients.. PubMed. 23(1 Pt 2). 1256–7. 16 indexed citations
11.
Kupin, Warren, et al.. (1991). REMOVAL OF LYMPHOCYTOTOXIC ANTIBODIES BY PRETRANSPLANT IMMUNOADSORPTION THERAPY IN HIGHLY SENSITIZED RENAL TRANSPLANT RECIPIENTS. Transplantation. 51(2). 324–329. 40 indexed citations
12.
Morán, M, Martin F. Mozes, Michael S. Maddux, et al.. (1990). Prevention of Acute Graft Rejection by the Prostaglandin E1Analogue Misoprostol in Renal-Transplant Recipients Treated with Cyclosporine and Prednisone. New England Journal of Medicine. 322(17). 1183–1188. 114 indexed citations
13.
Maddux, Michael S., et al.. (1989). Effective prophylaxis of early post-transplant urinary tract infections (UTI) in the cyclosporine (CSA) era.. PubMed. 21(1 Pt 2). 2108–9. 10 indexed citations
14.
Lazda, Velta A., Raymond Pollak, Martin F. Mozes, & Olga Jonasson. (1988). THE RELATIONSHIP BETWEEN FLOW CYTOMETER CROSSMATCH RESULTS AND SUBSEQUENT REJECTION EPISODES IN CADAVER RENAL ALLOGRAFT RECIPIENTS. Transplantation. 45(3). 562–565. 86 indexed citations
15.
Chakrabarty, Krishna, Jayant Radhakrishnan, Roohollah Sharifi, et al.. (1988). Lipogenic activity and brown fat content of human perirenal adipose tissue. Clinical Biochemistry. 21(4). 249–254. 8 indexed citations
16.
Pollak, Raymond, et al.. (1986). Anatomic abnormalities of cadaver kidneys procured for purposes of transplantation.. PubMed. 52(5). 233–5. 87 indexed citations
17.
Pollak, Raymond, et al.. (1980). Azathioprine-induced leukopenia—Clinical significance in renal transplantation. Journal of Surgical Research. 29(3). 258–264. 24 indexed citations
18.
Matas, Arthur J., et al.. (1976). IMMUNOPATHOLOGICAL STUDIES OF THE RUPTURED HUMAN RENAL ALLOGRAFT. Transplantation. 22(5). 420–426. 15 indexed citations
19.
Ziprkowski, L, M Schewach-Millet, Miriam Sandbank, & Martin F. Mozes. (1971). [Arterial thrombosis during corticosteroid therapy].. PubMed. 80(10). 540–3. 1 indexed citations
20.
Adar, R, et al.. (1970). [Paraplegia as a late complication of a septic aorto-iliac graft].. PubMed. 78(1). 3–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. E. R. Sutherland Breakdown of academic impact, for papers by William Pfaff Breakdown of academic impact, for papers by Martin L. Milgrom Breakdown of academic impact, for papers by P. R. Rajagopalan Breakdown of academic impact, for papers by Angelo DeMattos Breakdown of academic impact, for papers by E. Bertoni Breakdown of academic impact, for papers by Belzer Fo Breakdown of academic impact, for papers by T. Wujciak Breakdown of academic impact, for papers by K. Venkateswara Rao Breakdown of academic impact, for papers by T Tojimbara
Rankless by CCL
2026